Keysight Technologies Third Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

August 21, 2025

Simply Wall St

NYSE:KEYS 1 Year Share Price vs Fair Value

Explore Keysight Technologies's Fair Values from the Community and select yours

Keysight Technologies (NYSE:KEYS) Third Quarter 2025 Results

Key Financial Results

Revenue: US$1.35b (up 11% from 3Q 2024).
Net income: US$191.0m (down 51% from 3Q 2024).
Profit margin: 14% (down from 32% in 3Q 2024). The decrease in margin was driven by higher expenses.
EPS: US$1.11 (down from US$2.24 in 3Q 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

earnings-and-revenue-growth — NYSE:KEYS Earnings and Revenue Growth August 21st 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Keysight Technologies Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 2.6%. Earnings per share (EPS) missed analyst estimates by 19%.

Looking ahead, revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 8.1% growth forecast for the Electronic industry in the US.

Performance of the American Electronic industry.

The company's shares are down 6.9% from a week ago.

Risk Analysis

We should say that we've discovered 2 warning signs for Keysight Technologies that you should be aware of before investing here.

Valuation is complex, but we're here to simplify it.

Discover if Keysight Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

mitchell_lawler

A landmark settlement is meant to punish Meta (META). If the 1998 tobacco deal is any guide, it might protect it.

108

zoe_vi5fn16h

Any moat with an opt-out clause for your competitors is just a fence around your own garden.

connor_iwn1g16h

Worth looking at what previous legal action actually did to Meta rather than reaching for tobacco. The FTC's record five billion dollar privacy fine in 2019 was met with the stock rising, because it came in below fears and removed an open question. GDPR was designed to constrain large platforms and increased their share of the European ad market, because compliance cost fell hardest on small intermediaries. The FTC's antitrust case, the one that could genuinely have broken the company up, was decided in Meta's favour last November. The only thing that ever meaningfully hurt the business was Apple changing a tracking default, and Meta out-spent that too, while the ad-tech firms that could not afford to rebuild disappeared. The pattern is not that Meta survives regulation. It is that regulation keeps costing its smaller competitors more.